SEK 1.4
(-1.27%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -58.68 Million SEK | -15.3% |
2022 | -35.07 Million SEK | 3.61% |
2021 | -32.15 Million SEK | -32.2% |
2020 | -30.39 Million SEK | 28.49% |
2019 | -48.51 Million SEK | -58.38% |
2018 | -27.6 Million SEK | -58.35% |
2017 | -18.64 Million SEK | -46.35% |
2016 | -12.47 Million SEK | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | -11.98 Million SEK | -10.04% |
2024 Q3 | -10.48 Million SEK | 33.41% |
2024 Q1 | -11.18 Million SEK | 29.26% |
2023 Q4 | -15.34 Million SEK | -62.07% |
2023 FY | - SEK | -15.3% |
2023 Q3 | -9.46 Million SEK | 18.48% |
2023 Q1 | -14.88 Million SEK | -65.66% |
2023 Q2 | -11.61 Million SEK | 21.97% |
2022 Q4 | -8.98 Million SEK | 13.05% |
2022 Q3 | -10.33 Million SEK | 23.99% |
2022 FY | - SEK | 3.61% |
2022 Q1 | -10.92 Million SEK | 28.53% |
2022 Q2 | -13.59 Million SEK | -24.43% |
2021 Q3 | -9.73 Million SEK | 0.0% |
2021 Q4 | -15.28 Million SEK | -56.95% |
2021 FY | - SEK | -32.2% |
2020 FY | - SEK | 28.49% |
2019 FY | - SEK | -58.38% |
2018 FY | - SEK | -58.35% |
2017 FY | - SEK | -46.35% |
2016 FY | - SEK | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Neola Medical AB (publ) | -7.57 Million SEK | -674.529% |
Nosa Plugs AB | -44.97 Million SEK | -30.48% |